As health care costs continue to soar, health insurers are clamping down on costly procedures and medications and are targeting certain services in particular, such as diagnostic imaging and outpatient surgery, a new survey says. Tests getting increased scrutiny for suspected overuse include CAT scans and MRIs.

Related Summaries